CEACAM1 and metabolic dysfunction-associated steatohepatitis: In support of the role of hepatic CEACAM1 in atherosclerosis, mice with liver-specific Ceacam1 deletion developed NASH and atherogenic plaques when propagated on Ldlr−/− background and fed a high-cholesterol diet [21].